Children's Memorial Health Institute

What Children's Memorial Health Institute does

Children's Memorial Health Institute (Instytut "Pomnik-Centrum Zdrowia Dziecka" / IPCZD) is Poland's largest tertiary pediatric reference hospital and a Category A scientific research institute, headquartered in Warsaw and operating across 17 buildings. The institute delivers inpatient and outpatient pediatric specialty care (excluding hematology and orthopedics) to approximately 250,000 patients annually (2022), and conducts one of the country's most active pediatric clinical research programs — averaging roughly 75 trials per year over the past five years across 30 specialized units with 80 qualified investigators. Its research platform centers on the Pediatric Clinical Trials Support Center (CWpediBK), the only standalone pediatric clinical trials facility in Poland, complemented by the Pediatric Regional Center for Digital Medicine (PERCMC), an in-house Biobank, and a proprietary Clinical Trial Management System (SZBAK).

Core operations are organized around three integrated streams: clinical care (inpatient wards, outpatient clinics, day hospital, emergency department, and specialized centers for epilepsy, rare diseases, and transplant medicine), non-commercial clinical research (multi-year ABM-funded trials such as ViRap, DIPGen, RaRE-TS, BraimTOR, VEDI-UC, pedDUET-CD, PRIFEN, MitBrain, and MEDWAY), and commercial clinical trial support for pharmaceutical sponsors. Notable technical capabilities include pediatric liver and kidney transplantation programs among the largest globally, and a national coordination role for the European conect4children (c4c) network and the POLPEDNET consortium of 10 Polish academic-clinical units.

The institute is a public state entity supervised by the Polish Minister of Health. It is funded primarily through Poland's National Health Fund (NFZ) for clinical services and through Medical Research Agency (ABM) grants and state budget allocations for research. Cumulative ABM grant awards since 2020 exceed PLN 154 million across the listed trial portfolio. The institute holds DNV ISO 9001, FDA Inspection, MRA Inspection, HR Excellence in Research, and Accreditation Certificate No. 2022/60, and participates in multiple European Reference Networks (ERN-ITHACA, TRANSPLANT-CHILD, EpiCare).

Name

Children's Memorial Health Institute

Legal name

Instytut "Pomnik-Centrum Zdrowia Dziecka"

Website

https://czd.pl

Company type

Private

Founded year

1977

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Children's Memorial Health Institute (IPCZD) is Poland's largest tertiary pediatric hospital and Category A research institute, delivering specialty pediatric care to ~250,000 patients annually and operating the country's only standalone pediatric clinical trials center in Warsaw.

Ownership category

akta.pro rank

Product category

Pediatric Tertiary Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro industry

PRIMARYHLAFAJAG

Children’s Hospitals & Pediatric Health Systems

Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers

SECONDARYHLAFAJAH

Pediatric Specialty Care Centers (e.g., cardiology, oncology, neurology)

Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers

SECONDARYHLAIAIAN

Rare Pediatric & Congenital Disorder Therapies

Healthcare & Life Sciences/Pharmaceuticals/Orphan & Rare Disease Pharmaceuticals

Keywords

• Pediatric tertiary care
• Pediatric clinical trials
• Rare disease treatment
• Pediatric research institute
• Specialty hospital services

Headquarters

HQ city

Warszawa

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Distribution channels1 record

Marketing channels3 records

Core offering

Children's Memorial Health Institute is a public tertiary pediatric hospital and research institute delivering multi-specialty inpatient and outpatient clinical care to children across Poland, and operating a Pediatric Clinical Trials Support Center (CWpediBK) that conducts an average of 75 commercial and non-commercial clinical trials per year for pediatric medicinal products. It also runs digital medicine research, a Biobank, simulation-based pediatric education, and national coordination of European pediatric research networks (c4c, POLPEDNET, ERN).

Product overview

Children's Memorial Health Institute (Instytut Pomnik-Centrum Zdrowia Dziecka, IPCZD) is Poland's largest and most modern tertiary pediatric hospital and research institute. The institute operates as a platform of integrated healthcare, research, and educational services. Core clinical offerings include pediatric specialty services across all fields except hematology and orthopedics, supported by advanced diagnostic facilities. The institute's research infrastructure centers on the Pediatric Clinical Trials Support Center (CWpediBK), which manages both commercial and non-commercial clinical trials. Key research trials include VI-Rap (tuberous sclerosis), DIPGen (DIPG brain tumors), RaRE-TS (epilepsy), BraimTOR (CNS diseases), VEDI-UC (ulcerative colitis), pedDUET-CD (Crohn's disease), PRIFEN (diabetes), MitBrain (mitochondrial disease), and MEDWAY (medulloblastoma). Digital health services include the e-Pacjent Portal for electronic patient registration and the Proflab online laboratory results system. The institute also operates proprietary clinical trial management systems and participates in European research networks including conect4children (c4c) and POLPEDNET. Educational offerings include medical simulation training and specialized pediatric education programs.

Differentiator

Problem solved

Functional benefit

Brands

• CWpediBK - Centrum Wsparcia Pediatrycznych Badań Klinicznych: Jedyna samodzielna placówka pediatryczna w Polsce wspierająca badania kliniczne dedykowane populacji pediatrycznej. Misją jest zwiększenie wysokiej jakości badań etycznych poświęconych rozwojowi produktów leczniczych dla populacji dziecięcej.
• Proflab - Wyniki Online
• Hotel Patron
• conect4children (c4c)
• ePacjent Portal

Products and services

• Pediatric Multi-Specialty Clinical Care Services Tertiary multi-specialty pediatric inpatient and outpatient clinical care delivered across nearly all pediatric specialties except hematology and orthopedics, through 30 specialized units, 17 buildings, day hospital units, outpatient clinics, emergency department, and specialized centers (Epilepsy Center, Rare Diseases Center, Pediatric Surgery Unit). Includes one of the world's largest pediatric liver and kidney transplantation programs.
• Pediatric Clinical Trials Support Center (CWpediBK) Standalone pediatric facility supporting high-quality ethical research dedicated to medicinal product development for pediatric populations. Conducts both commercial and non-commercial clinical trials, including modeling, simulation, and extrapolation methods. Operates with FDA and MRA inspection certifications and ISO 9001 quality management.
• e-Pacjent Portal Electronic patient portal providing e-registration, electronic admission forms, and access to hospital services for patients and families. Available at epacjent.czd.pl.
• Proflab Online Laboratory Results System Online laboratory results system enabling patients to access test results using order number and PESEL, and healthcare providers to manage diagnostic data. Operates at wynikilab.czd.pl.
• SZBAK Clinical Trial Management System Proprietary clinical trial management system developed in-house at IPCZD for managing research operations across commercial and non-commercial pediatric trials. Expanded with new functionalities based on current needs of researchers, sponsors, and staff.
• Pediatric Regional Center for Digital Medicine (PERCMC) including Biobank Digital medicine center supporting clinical research with advanced bioinformatics and AI-driven solutions, combined with a Biobank for storing biological samples supporting translational and clinical research.
• POLPEDNET - Polish Paediatric Clinical Trials Network Coordination National coordination of POLPEDNET, comprising 10 academic-clinical units across Poland to strengthen cooperation in the Polish pediatric clinical trials market. Linked to the European conect4children network.
• Conect4children (c4c) National Hub Coordination National Hub coordination for the European conect4children network, which develops new medicinal products and therapies for the pediatric population, involving nearly 500 scientific, clinical, and pharmaceutical industry partners.
• Pediatric Simulation Center Medical simulation facilities providing pediatric education and training, including pediatric cardiac simulation and minimally invasive pediatric surgery simulation.
• Hospital Pharmacy Services Modernized hospital pharmacy providing pharmaceutical care with enhanced digitalization and pharmacotherapy safety systems for inpatient and outpatient pediatric services.
• VoiceBot Patient Appointment Cancellation Service Automated telephone-based VoiceBot system enabling patients to cancel appointments via dedicated phone number 22 122 59 60.

Quantifiable outcome

• 250,000 patients served annually (2022)
• +1 more outcomes

Segments1 record

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration12 records

Feature5 records

Partnerships

Twelve partnerships are on record, tiered core and minor.

• Conect4children (c4c)coreStrategic or Co-development PartnerIPCZD serves as the National Hub (NH) for the European conect4children network, which aims to develop new medicinal products and therapies for the pediatric population. The network involves nearly 500 scientific, clinical, and pharmaceutical industry partners. IPCZD coordinates Polish pediatric clinical research market through POLPEDNET as part of c4c.
• European Reference Networks (ERN)coreStrategic or Co-development PartnerIPCZD participates in multiple European Reference Networks (ERN) for rare diseases, including ERN for neurology (ERN-ITHACA), transplant (TRANSPLANT-CHILD), and epilepsy (EpiCare), connecting the institute with European centers of expertise for rare and complex pediatric conditions.
• POLPEDNET (Polish Paediatric Clinical Trials Network)coreStrategic or Co-development PartnerIPCZD coordinates POLPEDNET, which comprises 10 academic-clinical units across Poland. The network is designed to strengthen cooperation in the Polish pediatric clinical trials market and is linked to conect4children.
• Ginekkologiczno-Położniczy Szpital Kliniczny UM w Poznaniu (TREOCAPA study)minorStrategic or Co-development PartnerPartner site in the non-commercial TREOCAPA clinical trial on prophylactic treatment of patent ductus arteriosus in premature infants using acetaminophen.
• Brigham and Women's Hospital, Boston, USAcoreStrategic or Co-development PartnerInternational research partner providing consultation for non-commercial clinical trials including ViRap (TSC), RaRE-TS (drug-resistant epilepsy), and BraimTOR (mTOR pathway CNS diseases). Also involved in molecular genetic research collaborations.
• Transition Technologies-Science Sp. z o.o.coreTechnology or IntegrationAnalytical partner for multiple non-commercial clinical trials (ViRap, RaRE-TS, BraimTOR) providing bioinformatics, data analytics, and modeling & simulation support. Developed in-house clinical trial management system SZBAK.
• Uniwersytet Medyczny w ŁodzicoreStrategic or Co-development PartnerClinical and laboratory partner for ViRap, RaRE-TS, and PRIFEN non-commercial clinical trials. Collaborates on molecular genetics and biomarker research, including partnership with Harvard Medical School for RaRE-TS.
• Górnośląskie Centrum Zdrowia Dziecka w KatowicachminorStrategic or Co-development PartnerClinical partner for the DIPGen non-commercial trial on diffuse intrinsic pontine glioma (DIPG), where approximately 20 patients will be enrolled.
• Krajowe Forum na rzecz terapii chorób rzadkich – ORPHANminorStrategic or Co-development PartnerPatient advocacy organization for rare diseases participating in the BraimTOR project as a partner connecting patient associations.
• Fundacja GLIOMAminorStrategic or Co-development PartnerPatient foundation supporting DIPGen trial participants and parents, facilitating communication between researchers and trial participants, and sharing disease and treatment information.
• Ryvu TherapeuticsminorStrategic or Co-development PartnerPolish pharmaceutical company holding intellectual property rights to RVU120 (romaciclib), the CDK8/19 inhibitor being evaluated in the MEDWAY Phase I clinical trial for medulloblastoma.
• Zakład Genetyki WUMminorStrategic or Co-development PartnerGenetics laboratory partner for DIPGen, performing NGS sequencing and analysis libraries.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Ospedale Pediatrico Bambino Gesù: Italy's leading pediatric research hospital, Vatican-owned but operationally comparable as a tertiary pediatric referral and clinical research center. Strong participation in European pediatric research networks including ERN.
• Great Ormond Street Hospital for Children (GOSH): UK's largest pediatric tertiary and research hospital, part of the conect4children (c4c) network and a leading European pediatric clinical trials site. Directly comparable as a large, publicly funded pediatric research hospital with extensive specialty coverage and trial activity.
• Erasmus MC Sophia Children's Hospital: Major Dutch university pediatric hospital with research focus and c4c participation. Comparable as a publicly funded tertiary pediatric center with significant clinical trials throughput and EU network integration.
• Hospital Sant Joan de Déu Barcelona: Major Spanish pediatric teaching and research hospital and active c4c / ERN member with deep clinical trials portfolio. Comparable in operating model (public hospital + research) and pediatric specialty breadth.
• Necker–Enfants Malades Hospital (AP-HP): France's flagship university pediatric hospital with extensive research activity and rare disease specializations. Highly comparable as a publicly funded, EU-based pediatric research and tertiary care institution participating in ERN.

Broad incumbents

• Boston Children's Hospital: World's largest pediatric research hospital and top recipient of NIH pediatric funding. Comparable in mission (tertiary pediatric care + research leadership) though operated in a private/nonprofit US context.
• Children's Hospital of Philadelphia (CHOP): US pediatric research leader with extensive clinical trials activity across all pediatric specialties. Comparable in scale and research orientation, though structured as a private nonprofit in a different healthcare system.
• Karolinska University Hospital (Children's Hospital): Sweden's premier university hospital with a dedicated children's hospital and strong pediatric research footprint. Comparable as a publicly funded academic pediatric center with European research network participation.
• Charité – Universitätsmedizin Berlin (Pediatrics): Germany's largest university hospital with a substantial pediatric department and clinical trial infrastructure. Comparable as a publicly funded academic medical center conducting pediatric specialty research and clinical trials within national and EU networks.

Others

• conect4children (c4c) Coordination Office: European pediatric clinical trials network of which IPCZD is the Polish National Hub. Functionally a peer ecosystem: other National Hubs coordinate competing national pediatric trial portfolios and collaborate with the same pharma sponsors.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/CentrumZdrowiaDziecka

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Children's Memorial Health Institute